Key result
Evidence review outlines medical, invasive, and noninvasive strategies to lower noncardiac surgery risk.
Why the study?
Various guidelines and risk indices have optimized cardiac risk stratification, with a shift in emphasis toward reducing perioperative risk for noncardiac surgery.
Answers are grounded in this paper and cite their sources.
Various guidelines and risk indices have optimized cardiac risk stratification, and the emphasis has shifted to reducing perioperative risk. This review is an update on invasive (CABG/PCI) and noninvasive (medical therapy with beta‐blockers, alpha‐agonists, and statins) strategies to reduce cardiac risk for noncardiac surgery and the controversies surrounding their use. Journal of Hospital Medicine 2007;2:174–180.
No takes yet. Share an insight, caveat, or question.
Cohn et al. (2007) conducted a review in Perioperative cardiac risk for noncardiac surgery. Invasive (CABG/PCI) and noninvasive (medical therapy) strategies was evaluated. This review updates the evidence on invasive and noninvasive strategies, including medical therapy, to reduce perioperative cardiac risk for noncardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: